PGP and osteosarcoma: In the 37 osteosarcomas, wherepost-chemotherapy biopsies were available, there was no statisticallysignificant difference in Pgp expression in the pre- and post-chemotherapybiopsies, respectively (P = .10), although the MDR-score changed fromresistance to chemotherapy sensitive status in 4 cases (Table 5).